INBXInhibrx Biosciences, Inc.

$114.78

$23.0052 weeks$141.84

Price

$114.78+381%1Y

1M+34%1Y+381%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Top tier

10/10

Value89

Quality-

Momentum97

Growth-

Strongest Momentum, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

We are a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using our proprietary modular protein engineering platforms. We leverage our innovative protein engineering technologies and deep understanding of target biology to create therapeutic candidates with attributes and mechanisms we believe to be superior to current approaches and applicable to a range of challenging, validated targets with high potential.

In the company’s own words · 10-K filed Mar 19, 2026 · SEC EDGAR

P/E (TTM)-

Market Cap$1.40B

1Y Return+381%

5Y Return-

For the full year FY2025, revenue was $1.3M (+550% year on year) and net income −$140M.